BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37990355)

  • 1. Reappraisal of Donor Age in Liver Transplantation: NASH as a Potential Target to Safely Utilize Old Liver Grafts.
    Kusakabe J; Kozato A; Tajima T; Bekki Y; Fujiki M; Tomiyama K; Nakamura T; Matsushima H; Hashimoto K; Sasaki K
    Transplantation; 2024 Jul; 108(7):e110-e120. PubMed ID: 37990355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
    Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
    J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should We Be Utilizing More Liver Grafts From Pediatric Donation After Circulatory Death Donors? A National Analysis of the SRTR from 2002 to 2017.
    Sasaki K; Nair A; Firl DJ; McVey JC; El-Gazzaz G; Diago Uso T; Fujiki M; Aucejo FN; Quintini C; Kwon CD; Hashimoto K; Miller CM; Eghtesad B
    Transplantation; 2021 Sep; 105(9):1998-2006. PubMed ID: 32947583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of center volume on outcomes of increased-risk liver transplants.
    Ozhathil DK; Li YF; Smith JK; Tseng JF; Saidi RF; Bozorgzadeh A; Shah SA
    Liver Transpl; 2011 Oct; 17(10):1191-9. PubMed ID: 21604357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Elderly Allografts in Liver Transplantation.
    Paterno F; Wima K; Hoehn RS; Cuffy MC; Diwan TS; Woodle SE; Abbott DE; Shah SA
    Transplantation; 2016 Jan; 100(1):153-8. PubMed ID: 26154390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.
    Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U
    Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.
    Haugen CE; Thomas AG; Garonzik-Wang J; Massie AB; Segev DL
    Transplantation; 2018 Sep; 102(9):1514-1519. PubMed ID: 29570165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor Age Still Matters in Liver Transplant: Results From the United Network for Organ Sharing-Scientific Registry of Transplant Recipients Database.
    Montenovo MI; Hansen RN; Dick AAS; Reyes J
    Exp Clin Transplant; 2017 Oct; 15(5):536-541. PubMed ID: 27759559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor Age-Based Analysis of Liver Transplantation Outcomes: Short- and Long-Term Outcomes Are Similar Regardless of Donor Age.
    Chapman WC; Vachharajani N; Collins KM; Garonzik-Wang J; Park Y; Wellen JR; Lin Y; Shenoy S; Lowell JA; Doyle MB
    J Am Coll Surg; 2015 Jul; 221(1):59-69. PubMed ID: 25872684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis.
    Molnar MZ; Joglekar K; Jiang Y; Cholankeril G; Abdul MKM; Kedia S; Gonzalez HC; Ahmed A; Singal A; Bhamidimarri KR; Aithal GP; Duseja A; Wong VW; Gulnare A; Puri P; Nair S; Eason JD; Satapathy SK;
    Liver Transpl; 2019 Mar; 25(3):399-410. PubMed ID: 30369023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis.
    Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK
    Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of "increased-risk" donor hearts on transplant outcomes: A propensity-matched analysis.
    Shudo Y; Cohen JE; Lingala B; He H; Zhu Y; Woo YJ
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):603-610. PubMed ID: 30669225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Combinations of Donor and Recipient Ages and Other Factors on Kidney Graft Outcomes.
    Gerbase-DeLima M; de Marco R; Monteiro F; Tedesco-Silva H; Medina-Pestana JO; Mine KL
    Front Immunol; 2020; 11():954. PubMed ID: 32528472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the Effect of Transplanting Older Donor Livers Into Younger Recipients: The Need for Donor-recipient Age Matching.
    Bittermann T; Goldberg DS
    Transplantation; 2018 Dec; 102(12):2033-2037. PubMed ID: 29965955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers.
    Benko T; Gallinat A; Minor T; Saner FH; Sotiropoulos GC; Paul A; Hoyer DP
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):716-722. PubMed ID: 28441690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of liver transplants from donors aged 70 plus: analysis of Andalusian transplant register.
    Franco CC; Martínez JM; Bellido CB; Artacho GS; Gómez LM; Diez-Canedo JS; Aunión CD; Ruiz FJ; Bravo MA
    Transplant Proc; 2013; 45(10):3647-9. PubMed ID: 24314984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
    Dirchwolf M; Dodge JL; Gralla J; Bambha KM; Nydam T; Hung KW; Rosen HR; Feng S; Terrault NA; Biggins SW
    Liver Transpl; 2015 Aug; 21(8):1022-30. PubMed ID: 26074140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation.
    Salvalaggio PR; Dzebisashvili N; MacLeod KE; Lentine KL; Gheorghian A; Schnitzler MA; Hohmann S; Segev DL; Gentry SE; Axelrod DA
    Liver Transpl; 2011 Mar; 17(3):233-42. PubMed ID: 21384505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.